ICU Medical, Inc. (NASDAQ:ICUI) Director Robert S. Swinney sold 3,400 shares of the firm’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $173.98, for a total transaction of $591,532.00. Following the completion of the sale, the director now directly owns 20,893 shares in the company, valued at $3,634,964.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Shares of ICU Medical, Inc. (NASDAQ ICUI) traded up 0.32% on Friday, reaching $174.90. 37,465 shares of the company’s stock were exchanged. The company has a market capitalization of $3.47 billion, a P/E ratio of 70.04 and a beta of 0.37. ICU Medical, Inc. has a 12 month low of $120.14 and a 12 month high of $176.50. The firm’s 50 day moving average price is $171.13 and its 200-day moving average price is $161.81.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share for the quarter, missing analysts’ consensus estimates of $0.58 by $0.06. The business had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. ICU Medical’s revenue for the quarter was up 242.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.15 EPS. On average, equities analysts anticipate that ICU Medical, Inc. will post $4.11 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “ICU Medical, Inc. (ICUI) Director Robert S. Swinney Sells 3,400 Shares” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.watchlistnews.com/icu-medical-inc-icui-director-robert-s-swinney-sells-3400-shares/1536643.html.

Several equities research analysts recently issued reports on the stock. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $193.00 target price on the stock in a research report on Thursday, July 20th. Sidoti cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a research report on Tuesday, June 20th. BidaskClub cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Gabelli reissued a “buy” rating on shares of ICU Medical in a research report on Friday, August 11th. Finally, Roth Capital cut shares of ICU Medical from a “buy” rating to a “neutral” rating in a research report on Thursday, May 11th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $193.00.

Several institutional investors have recently modified their holdings of ICUI. BlackRock Inc. increased its position in shares of ICU Medical by 0.6% in the second quarter. BlackRock Inc. now owns 1,780,976 shares of the medical instruments supplier’s stock worth $307,218,000 after buying an additional 11,046 shares in the last quarter. Janus Capital Management LLC increased its position in shares of ICU Medical by 178.8% in the first quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after buying an additional 923,395 shares in the last quarter. Janus Henderson Group PLC acquired a new position in shares of ICU Medical during the second quarter worth $247,072,000. Vanguard Group Inc. increased its position in shares of ICU Medical by 16.3% in the second quarter. Vanguard Group Inc. now owns 1,304,282 shares of the medical instruments supplier’s stock worth $224,989,000 after buying an additional 183,133 shares in the last quarter. Finally, Wellington Management Group LLP increased its position in shares of ICU Medical by 12.1% in the first quarter. Wellington Management Group LLP now owns 652,897 shares of the medical instruments supplier’s stock worth $99,697,000 after buying an additional 70,283 shares in the last quarter. Institutional investors own 78.13% of the company’s stock.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.